Skip to content
Screener

Savara SVRA Operating Cash Flow

Operating Cash Flow at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$8.26M+4,440%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$51.97M+17.9%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$17.03M+573%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
-$47.85M-16.2%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$56.67M-25.3%
PVL
Palvella TherapeuticsPVLA
-$10.86M-60.5%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+151%
Enterprise value$1.18B+142%

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Savara’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:05 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219371
Line itemFor the three months ended March 31, 2026For the three months ended March 31, 2025
Prepaid expenses and other current assets(639)859
Non-current assets(864)(768)
Accounts payable and accrued expenses and other current liabilities(4,635)(3,148)
Net cash used in operating activities(33,046)(27,189)
Cash flows from investing activities:
Purchase of property and equipment(54)(3)
Purchase of available-for-sale securities, net(15,068)
Maturity of available-for-sale securities25,70044,400

Cover / Front Matter

FAQ

What is Savara's operating cash flow?
Savara (SVRA) reported operating cash flow of -$33.05M in Q1 2026.
How has Savara's operating cash flow changed year-over-year?
Savara's operating cash flow decreased by 21.5% year-over-year, from -$27.19M to -$33.05M.
What is the long-term trend for Savara's operating cash flow?
Over 4 years (2021 to 2025), Savara's operating cash flow has grown at a 26.0% compound annual growth rate (CAGR), from -$40.08M to -$101.04M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Savara's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude